4Sarah Czok ,Jenna R, Zechmeister, et al. Advanced endometrial canc- er: Is there a benefit to neoadjuvant therapy [ J ]. American Society of Clinical Oncology, 2012,30 ( 15 suppl) : 15548.
5Cohen C J, Brukner HW, Deppe G, et al. Multidrug treatment of ad- vanced and recurrent endometrial carcinoma:a Gynecologic Oncology Group study[J]. Obstetrics & Gynecology, 1984,63 (5) :719.
6Scarabell C, Campagnutta E, Giorda G, et al. Maxincal cytoreductive surgery as a reasonable therapeutical ternative for recurrent endometri- al carcinoma[ J]. Gynecol Onco1,1998,70( 1 ) :90.
7Barrett RJ, Blessing JA, Homesley HD, et al. Circadian-timed combi- nation of doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase Ⅱ study of the Gynecol Oncology Group [ J ]. Am J Clin 0nco1,1993,16(6) :494.
8Gargett CE, Chan RW, Schwab KE, et al. Hormone and growth factor signoting in endometrial renewal: role of stem/progenitor ceils [ J ]. Mol Cell Endecrinol,2008,288( 1 -2) :22.
9Bruzzone M, Miglietta L, Franzone P, et al. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage Ⅲ-Ⅷ endo- metrial cancer patients [J]. Gynecol Onco1,2004,93 ( 2 ) :345.
10Lupe KD, Souza DP, Kwon JS, et al. Adjuvant carboplatin and paelita- xel chemotherapy interposed with involved field radiation for advanced endometrial cancer [ J ]. Gynecol Oncol, 2009,114 ( 1 ) : 94.
